Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDAK Codiak BioSciences	$0.00	$0.00	$0.05 ▼ $6.98	$59K	3.71	1.37 million shs	N/A
CDAKQ Codiak BioSciences	$0.00	$0.00	$0.00 ▼ $3.26	$59K	3.43	905,289 shs	N/A
SXTC China SXT Pharmaceuticals	$1.89 +1.6%	$1.81	$0.95 ▼ $11.92	$29.44M	1.11	1.19 million shs	53,178 shs
VIVE Viveve Medical	$0.00	$0.00	$0.00 ▼ $0.02	$1K	0.11	2,984 shs	1,985 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDAK Codiak BioSciences	0.00%	0.00%	0.00%	0.00%	0.00%
CDAKQ Codiak BioSciences	0.00%	0.00%	0.00%	0.00%	0.00%
SXTC China SXT Pharmaceuticals	+7.51%	-11.85%	+55.00%	-30.34%	-78.27%
VIVE Viveve Medical	0.00%	0.00%	0.00%	-50.00%	-66.67%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CDAK Codiak BioSciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CDAKQ Codiak BioSciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	0.4212 of 5 stars	0.0	3.0	0.0	0.0	1.8	0.0	0.6
VIVE Viveve Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
CDAK Codiak BioSciences	N/A	N/A	N/A
CDAKQ Codiak BioSciences	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	N/A	N/A	N/A
VIVE Viveve Medical	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CDAK Codiak BioSciences	$33.57M	0.00	N/A	N/A	$2.39 per share	0.00
CDAKQ Codiak BioSciences	$22.93M	0.00	N/A	N/A	$2.39 per share	0.00
SXTC China SXT Pharmaceuticals	$1.93M	15.50	N/A	N/A	$243.66 per share	0.01
VIVE Viveve Medical	$6.83M	0.00	N/A	N/A	N/A	∞

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CDAK Codiak BioSciences	-$37.16M	-$0.69	N/A	∞	N/A	-51.13%	-109.51%	-34.44%	N/A
CDAKQ Codiak BioSciences	-$37.16M	-$0.69	N/A	∞	N/A	N/A	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	-$3.10M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
VIVE Viveve Medical	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CDAK Codiak BioSciences	N/A	N/A	N/A	N/A	N/A
CDAKQ Codiak BioSciences	N/A	N/A	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
VIVE Viveve Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CDAK Codiak BioSciences	0.66	4.24	4.24
CDAKQ Codiak BioSciences	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	0.01	1.40	1.35
VIVE Viveve Medical	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CDAK Codiak BioSciences	71.30%
CDAKQ Codiak BioSciences	25.32%
SXTC China SXT Pharmaceuticals	5.02%
VIVE Viveve Medical	N/A

Insider Ownership

Company	Insider Ownership
CDAK Codiak BioSciences	8.20%
CDAKQ Codiak BioSciences	8.20%
SXTC China SXT Pharmaceuticals	3.95%
VIVE Viveve Medical	5.73%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CDAK Codiak BioSciences	102	36.83 million	33.81 million	Not Optionable
CDAKQ Codiak BioSciences	102	36.83 million	33.81 million	Optionable
SXTC China SXT Pharmaceuticals	90	15.83 million	15.20 million	Not Optionable
VIVE Viveve Medical	70	10.67 million	N/A	Not Optionable

VIVE, SXTC, CDAK, and CDAKQ Headlines

Recent News About These Companies

Sharing medical and

October 25, 2024 | news-medical.net

Viveve Medical Inc (VIVE)

July 24, 2024 | investing.com

Incontinence Devices Pipeline Research Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

July 19, 2024 | finance.yahoo.com

Vaginal Rejuvenation Is Big Business

July 19, 2024 | ca.style.yahoo.com

5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028

April 17, 2024 | finance.yahoo.com

InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL

April 15, 2024 | finance.yahoo.com

Viveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, Predictions

February 23, 2024 | benzinga.com

The Best Medical Billing Services of 2024

January 19, 2024 | business.com

VIVE Viveve Medical, Inc.

July 29, 2023 | seekingalpha.com

InMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve Patents

July 25, 2023 | finance.yahoo.com

VIVE - Viveve Medical, Inc.

June 14, 2023 | uk.finance.yahoo.com

Viveve Medical, Inc. (VIVE)

February 24, 2023 | finance.yahoo.com

Viveve Medical announces study result from PURSUIT clinical trial to treat female stress urinary incontinence

January 20, 2023 | pharmabiz.com

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

January 17, 2023 | msn.com

Viveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence

January 17, 2023 | finanznachrichten.de

Viveve crashes ~60% as company decides to delist, explore sale after trial fails

January 17, 2023 | seekingalpha.com

Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence

January 17, 2023 | finance.yahoo.com

Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial

January 17, 2023 | finance.yahoo.com

Why Is Viveve Medical (VIVE) Stock Down 69% Today?

January 17, 2023 | investorplace.com

Viveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call Transcript

December 29, 2022 | insidermonkey.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
Analysts Think These Stocks Could More Than Double in Value
By Nathan Reiff | May 23, 2025
View Analysts Think These Stocks Could More Than Double in Value
Intel’s Turnaround May Be the Best Bet No One’s Watching
By Jeffrey Neal Johnson | May 30, 2025
View Intel’s Turnaround May Be the Best Bet No One’s Watching
Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
By Thomas Hughes | May 27, 2025
View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
By Sam Quirke | June 7, 2025
View X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back

VIVE, SXTC, CDAK, and CDAKQ Company Descriptions

Codiak BioSciences NASDAQ:CDAK

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Codiak BioSciences NASDAQ:CDAKQ

China SXT Pharmaceuticals NASDAQ:SXTC

$1.89 +0.03 (+1.61%)

Closing price 04:00 PM Eastern

Extended Trading

$1.86 -0.03 (-1.80%)

As of 07:56 PM Eastern

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

Viveve Medical NASDAQ:VIVE

$0.0001 0.00 (0.00%)

As of 12:52 PM Eastern

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time